Cargando…
MT2A is an early predictive biomarker of response to chemotherapy and a potential therapeutic target in osteosarcoma
Osteosarcoma is the most prevalent primary bone malignancy in children and young adults. Resistance to chemotherapy remains a key challenge for effective treatment of patients with osteosarcoma. The aim of the present study was to investigate the preventive role of metallothionein-2A (MT2A) in respo...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707240/ https://www.ncbi.nlm.nih.gov/pubmed/31444479 http://dx.doi.org/10.1038/s41598-019-48846-2 |